Safety and efficacy of delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors over 55 years of age

Transplantation Proceedings

Volumn 35, Issue 5, 2003, Pages 1706-1708

  Gentil, M A ^a   Osuna, A ^a   Capdevila, L ^a   Rodriguez Algarra, G ^a   Cantarell, C ^a   Pereira, P ^a   Gonzalez Molina M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GRAFT REJECTION; HEART DEATH; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; PRIORITY JOURNAL; RECIPIENT; SEPSIS; URINARY TRACT INFECTION;

EID: 0042833260     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00609-2     Document Type: Conference Paper

References (7)

1. Ojo A.O., Wolfe R.A., Held P.J., et al. Transplantation. 63:1997;968.
2. Shoskes D.A., Cecka J.M. Transplantation. 66:1998;1697.
3. Tullius S.G., Volk H.D., Neuhaus P. Transplantation. 72:2001;1341.
4. Kasiske B.L., Snyder J. J Am Soc Nephrol. 13:2002;1067.
5. Sola R., Guirado L., Diaz J.M., et al. Transplantation. 73:2002;1673.
6. Nankivell B.J., Fenton-Lee C.A., Kuypers D.R.J., et al. Transplantation. 71:2001;515.
7. Meier-Kriesche H.U., Ojo A.O., et al. Transplantation. 70:2000;306.